ICCC
#3958
ImmuCell Corporation - Common Stock
11.7 2 USD
+0.06%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+5.78%
Changement Mensuel
+23.11%
Evolution sur 6 mois
+72.61%
Changement Annuel
+84.86%
Clôture Précédente
11.0 8
Open
11.7 2
Low
11.7 2
High
11.7 2
Volume
5
Financials
- Market Capitalization 106.03 M
- Employee 73
- Founded 1982
- CEO Michael F Brigham
- Website www.immucell.com
- Headquarter Delaware, United States
- FIGI BBG000BLQ5Q2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-90.43
ratio cours/chiffre d'affaires
1.91
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3946 |  KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.55 USD | +2.94% | -6.76% | +3.41% | -55.52% | 108.25 M USD | ||
| 3955 |  BDTX Black Diamond Therapeutics, Inc. - Common Stock | 1.86 USD | -2.11% | -8.82% | +7.51% | -36.95% | 106.58 M USD | ||
| 3976 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.93 USD | +0.17% | -1.33% | +1.72% | -1.50% | 101.87 M USD | ||
| 3989 |  SPRO Spero Therapeutics, Inc. - Common Stock | 1.70 USD | -22.02% | -20.56% | -42.37% | -31.73% | 98.43 M USD |